4D MOLECULAR THERAPE (FDMT) — News & AI sentiment

4D MOLECULAR THERAPE (FDMT) news roundup. 2 stories in the past week, 8 over 30 days. Average 30-day sentiment is 52.5/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 9 sales totalling $3.1M — net selling of $3.1M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

FDMT news in the last 24 hours, 7 days, 30 days and 90 days

How much FDMT coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.